ERBB2 and breast cancer: GLO1 overexpression does not correlate with different breast cancer subtypes, neither luminal A, Luminal B, Her2+ or TNBC (2.92±0.46, 3.12±0.48, 3.1±0.53 and 3.05±0.52 respectively; P = 0.06) (Figure 2).